{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:55:55Z","timestamp":1777496155709,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Centre of Postgraduate Medical Education in Warsaw","award":["501-1-020-19-25"],"award-info":[{"award-number":["501-1-020-19-25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28414-7","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:29:19Z","timestamp":1766582959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of previous SARS-CoV-2 infection on the severity of respiratory syncytial virus infection in hospitalized children"],"prefix":"10.1038","volume":"15","author":[{"given":"Barbara","family":"Poniedzia\u0142ek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Rozwadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Zab\u0142ocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Jackowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Rzymski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"28414_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/cid\/ciad289","volume":"77","author":"Z Teoh","year":"2023","unstructured":"Teoh, Z. et al. Burden of respiratory viruses in children less than 2 years old in a community-based longitudinal US birth cohort. Clin. Infect. Dis. 77, 901\u2013909 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"28414_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2023.10.023","volume":"138","author":"LK Dallmeyer","year":"2024","unstructured":"Dallmeyer, L. K. et al. Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis. Int. J. Infect. Dis. 138, 10\u201318 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"28414_CR3","doi-asserted-by":"publisher","first-page":"e29453","DOI":"10.1002\/jmv.29453","volume":"96","author":"P Rzymski","year":"2024","unstructured":"Rzymski, P. & Gwenzi, W. Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity. J. Med. Virol. 96, e29453 (2024).","journal-title":"J. Med. Virol."},{"key":"28414_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0140-6736(24)01716-1","volume":"404","author":"NI Mazur","year":"2024","unstructured":"Mazur, N. I., Caballero, M. T. & Nunes, M. C. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies. Lancet 404, 1143\u20131156 (2024).","journal-title":"Lancet"},{"key":"28414_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(24)00138-7","volume":"403","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: A systematic review and meta-analysis of aggregated and individual participant data. Lancet 403, 1241\u20131253 (2024).","journal-title":"Lancet"},{"key":"28414_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41423-022-00857-2","volume":"19","author":"CK Kang","year":"2022","unstructured":"Kang, C. K., Shin, H. M., Park, W. B. & Kim, H.-R. Why are children less affected than adults by severe acute respiratory syndrome coronavirus 2 infection?. Cell. Mol. Immunol. 19, 555\u2013557 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"28414_CR7","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","volume":"186","author":"J-G Cheong","year":"2023","unstructured":"Cheong, J.-G. et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell 186, 3882-3902.e24 (2023).","journal-title":"Cell"},{"key":"28414_CR8","doi-asserted-by":"publisher","first-page":"eado2099","DOI":"10.1126\/scitranslmed.ado2099","volume":"16","author":"SH Saydah","year":"2024","unstructured":"Saydah, S. H., Campbell, A. P. & Randolph, A. G. Consequences beyond acute SARS-CoV-2 infection in children. Sci. Transl. Med. 16, eado2099 (2024).","journal-title":"Sci. Transl. Med."},{"key":"28414_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00085-21","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. MBio 12, 10\u20131128 (2021).","journal-title":"MBio"},{"key":"28414_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-021-00749-3","volume":"6","author":"Y Jing","year":"2021","unstructured":"Jing, Y. et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct. Target. Ther. 6, 345 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"28414_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102089","volume":"61","author":"B Abu-Raya","year":"2023","unstructured":"Abu-Raya, B., Vi\u00f1eta Paramo, M., Reicherz, F. & Lavoie, P. M. Why has the epidemiology of RSV changed during the COVID-19 pandemic?. EClinicalMedicine 61, 102089 (2023).","journal-title":"EClinicalMedicine"},{"key":"28414_CR12","doi-asserted-by":"publisher","first-page":"1376389","DOI":"10.3389\/fmicb.2024.1376389","volume":"15","author":"N Korsun","year":"2024","unstructured":"Korsun, N. et al. Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022\u20132023 season. Front. Microbiol. 15, 1376389 (2024).","journal-title":"Front. Microbiol."},{"key":"28414_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1186\/s12879-024-09783-2","volume":"24","author":"H-F Liu","year":"2024","unstructured":"Liu, H.-F. et al. Comparison of characteristics of children hospitalized for respiratory syncytial virus infection during the pre- and post-COVID-19 eras: a multicenter retrospective study. BMC Infect. Dis. 24, 1009 (2024).","journal-title":"BMC Infect. Dis."},{"key":"28414_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13070741","author":"B Poniedzia\u0142ek","year":"2025","unstructured":"Poniedzia\u0142ek, B. et al. Seroprevalence of RSV IgG antibodies across age groups in poland after the COVID-19 pandemic: Data from the 2023\/2024 epidemic season. Vaccines https:\/\/doi.org\/10.3390\/vaccines13070741 (2025).","journal-title":"Vaccines"},{"key":"28414_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107052","volume":"144","author":"M Del Riccio","year":"2024","unstructured":"Del Riccio, M. et al. Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the global influenza surveillance and Response System (GISRS). Int. J. Infect. Dis. 144, 107052 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"28414_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/apm.70010","volume":"133","author":"GW Pratt","year":"2025","unstructured":"Pratt, G. W., Wong, C. L. & Rao, L. V. Prevalence and co-detection rates of SARS-CoV-2, influenza, and respiratory syncytial virus: A retrospective analysis. APMIS 133, e70010 (2025).","journal-title":"APMIS"},{"key":"28414_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41577-024-01067-9","volume":"25","author":"TJ Wells","year":"2025","unstructured":"Wells, T. J., Esposito, T., Henderson, I. R. & Labzin, L. I. Mechanisms of antibody-dependent enhancement of infectious disease. Nat. Rev. Immunol. 25, 6\u201321 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"28414_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1186\/s12879-021-06482-0","volume":"21","author":"AN Bonheur","year":"2021","unstructured":"Bonheur, A. N. et al. A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection. BMC Infect. Dis. 21, 749 (2021).","journal-title":"BMC Infect. Dis."},{"key":"28414_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011710","volume":"17","author":"CF Estofolete","year":"2023","unstructured":"Estofolete, C. F. et al. Influence of previous Zika virus infection on acute dengue episode. PLoS Negl. Trop. Dis. 17, e0011710 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"28414_CR20","doi-asserted-by":"publisher","unstructured":"Jakhar, K. et al. SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in-vitro and in-vivo. bioRxiv 2023.10.09.557914 (2023) https:\/\/doi.org\/10.1101\/2023.10.09.557914.","DOI":"10.1101\/2023.10.09.557914"},{"key":"28414_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.4269\/ajtmh.21-0586","volume":"105","author":"N Ravikumar","year":"2021","unstructured":"Ravikumar, N. et al. Impact of recent SARS-CoV-2 infection on the course and severity of dengue in children: A prospective observational study from north India. Am. J. Trop. Med. Hyg. 105, 751\u2013755 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"28414_CR22","doi-asserted-by":"crossref","unstructured":"Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 1\u20136 (2021).","DOI":"10.1101\/2021.06.24.21259087"},{"key":"28414_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41590-021-01123-9","volume":"23","author":"J Chou","year":"2022","unstructured":"Chou, J., Thomas, P. G. & Randolph, A. G. Immunology of SARS-CoV-2 infection in children. Nat. Immunol. 23, 177\u2013185 (2022).","journal-title":"Nat. Immunol."},{"key":"28414_CR24","first-page":"20143085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. 282, 20143085 (2015).","journal-title":"Proc. Biol. Sci."},{"key":"28414_CR25","doi-asserted-by":"publisher","first-page":"1268782","DOI":"10.3389\/fbioe.2023.1268782","volume":"11","author":"J Gonzalez-Rubio","year":"2023","unstructured":"Gonzalez-Rubio, J. et al. SARS-CoV-2 particles promote airway epithelial differentiation and ciliation. Front. Bioeng. Biotechnol. 11, 1268782 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"28414_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/v16050704","volume":"16","author":"J Mazela","year":"2024","unstructured":"Mazela, J. et al. Epidemiology of respiratory syncytial virus hospitalizations in Poland: An analysis from 2015 to 2023 covering the entire polish population of children aged under five years. Viruses 16, 704 (2024).","journal-title":"Viruses"},{"key":"28414_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107231","volume":"148","author":"V Lastrucci","year":"2024","unstructured":"Lastrucci, V. et al. Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study. Int. J. Infect. Dis. 148, 107231 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"28414_CR28","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1038\/s41467-024-47757-9","volume":"15","author":"E Rios-Guzman","year":"2024","unstructured":"Rios-Guzman, E. et al. Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic. Nat. Commun. 15, 3374 (2024).","journal-title":"Nat. Commun."},{"key":"28414_CR29","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/jcm14041387","volume":"14","author":"M Maglione","year":"2025","unstructured":"Maglione, M. et al. Changes in respiratory viruses\u2019 activity in children during the COVID-19 pandemic: A systematic review. J. Clin. Med. 14, 1387 (2025).","journal-title":"J. Clin. Med."},{"key":"28414_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127443","volume":"61","author":"P Rzymski","year":"2025","unstructured":"Rzymski, P. et al. Tracking clinical severity of influenza in adult hospitalized patients in 2024: Data from the FluTer registry in Poland. Vaccine 61, 127443 (2025).","journal-title":"Vaccine"},{"key":"28414_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00731-8","author":"P Rzymski","year":"2025","unstructured":"Rzymski, P. et al. Unraveling Poland\u2019s unprecedented influenza surge in early 2025: increased viral severity or post-pandemic vulnerability?. Pharmacol. Rep. https:\/\/doi.org\/10.1007\/s43440-025-00731-8 (2025).","journal-title":"Pharmacol. Rep."},{"key":"28414_CR32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/irv.12998","volume":"16","author":"M-N Billard","year":"2022","unstructured":"Billard, M.-N. et al. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures. Influenza Other Respi. Viruses 16, 926\u2013936 (2022).","journal-title":"Influenza Other Respi. Viruses"},{"key":"28414_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1473-3099(22)00544-8","volume":"23","author":"M-N Billard","year":"2023","unstructured":"Billard, M.-N. & Bont, L. J. Quantifying the RSV immunity debt following COVID-19: a public health matter. Lancet. Infect. Dis 23, 3\u20135 (2023).","journal-title":"Lancet. Infect. Dis"},{"key":"28414_CR34","doi-asserted-by":"publisher","first-page":"e29651","DOI":"10.1002\/jmv.29651","volume":"96","author":"P Rzymski","year":"2024","unstructured":"Rzymski, P. et al. The burden of infectious diseases throughout and after the COVID-19 pandemic (2020\u20132023) and Russo-Ukrainian war migration. J. Med. Virol. 96, e29651 (2024).","journal-title":"J. Med. Virol."},{"key":"28414_CR35","doi-asserted-by":"crossref","unstructured":"Rao, S. et al. P-727. Is there increased risk of RSV infection following SARS-CoV-2 infection in children? An EHR-based cohort study from the RECOVER Program. Open Forum Infect. Dis. 12, (2025).","DOI":"10.1093\/ofid\/ofae631.923"},{"key":"28414_CR36","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/ppul.25465","volume":"56","author":"A Giannattasio","year":"2021","unstructured":"Giannattasio, A. et al. Silent RSV in infants with SARS-CoV-2 infection: A case series. Pediatr. Pulmonol. 56, 3044\u20133046 (2021).","journal-title":"Pediatr. Pulmonol."},{"key":"28414_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/v14020395","volume":"14","author":"C Fage","year":"2022","unstructured":"Fage, C., H\u00e9naut, M., Carbonneau, J., Piret, J. & Boivin, G. Influenza A(H1N1)pdm09 virus but not respiratory syncytial virus interferes with SARS-CoV-2 replication during sequential infections in human nasal epithelial cells. Viruses 14, 395 (2022).","journal-title":"Viruses"},{"key":"28414_CR38","doi-asserted-by":"publisher","unstructured":"Morris, D. R. et al. The impact of RSV\/SARS-CoV-2 coinfection on clinical disease and viral replication: insights from a BALB\/c mouse model. bioRxivorg (2023) https:\/\/doi.org\/10.1101\/2023.05.24.542043.","DOI":"10.1101\/2023.05.24.542043"},{"key":"28414_CR39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221250","volume":"306","author":"R Heiss","year":"2023","unstructured":"Heiss, R. et al. Pulmonary dysfunction after pediatric COVID-19. Radiology 306, e221250 (2023).","journal-title":"Radiology"},{"key":"28414_CR40","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.3390\/jcm12216891","volume":"12","author":"E Shmueli","year":"2023","unstructured":"Shmueli, E. et al. Pulmonary evaluation in children with post-COVID-19 condition respiratory symptoms: A prospective cohort study. J. Clin. Med. 12, 6891 (2023).","journal-title":"J. Clin. Med."},{"key":"28414_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12887-024-04560-1","volume":"24","author":"E Bakhtiari","year":"2024","unstructured":"Bakhtiari, E. & Moazzen, N. Pulmonary function in children post -SARS-CoV-2 infection: a systematic review and meta-analysis. BMC Pediatr. 24, 87 (2024).","journal-title":"BMC Pediatr."},{"key":"28414_CR42","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357912","volume":"24","author":"VG Magalh\u00e3es","year":"2023","unstructured":"Magalh\u00e3es, V. G. et al. Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children. EMBO Rep. 24, e57912 (2023).","journal-title":"EMBO Rep."},{"key":"28414_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01276-23","volume":"97","author":"J Bragazzi Cunha","year":"2023","unstructured":"Bragazzi Cunha, J. et al. Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection. J. Virol. 97, e0127623 (2023).","journal-title":"J. Virol."},{"key":"28414_CR44","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","volume":"388","author":"B Kampmann","year":"2023","unstructured":"Kampmann, B. et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N. Engl. J. Med. 388, 1451\u20131464 (2023).","journal-title":"N. Engl. J. Med."},{"key":"28414_CR45","doi-asserted-by":"publisher","first-page":"ofae723","DOI":"10.1093\/ofid\/ofae723","volume":"12","author":"KE Rumfelt","year":"2025","unstructured":"Rumfelt, K. E. et al. Maternal-infant respiratory syncytial virus and influenza A virus antibody transfer in preterm and full-term infants. Open Forum Infect. Dis. 12, ofae723 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"28414_CR46","first-page":"16403","volume":"133","author":"K Dobrowolska","year":"2023","unstructured":"Dobrowolska, K. et al. Differences between the course of SARS-CoV-2 infections in the periods of the delta and omicron variant dominance in Poland. Pol. Arch. Intern. Med. 133, 16403 (2023).","journal-title":"Pol. Arch. Intern. Med."},{"key":"28414_CR47","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e224","volume":"38","author":"K Sangwha","year":"2023","unstructured":"Sangwha, K. et al. Frozen sections in decision-making regarding the axillary procedures in breast conserving surgery for intraductal carcinoma at preoperative diagnosis. J. Korean Med. Sci. 38, e224 (2023).","journal-title":"J. Korean Med. Sci."},{"key":"28414_CR48","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.3390\/jcm12175572","volume":"12","author":"R Flisiak","year":"2023","unstructured":"Flisiak, R. et al. Change in the clinical picture of hospitalized patients with COVID-19 between the early and late period of dominance of the omicron SARS-CoV-2 variant. J. Clin. Med. 12, 5572 (2023).","journal-title":"J. Clin. Med."},{"key":"28414_CR49","doi-asserted-by":"publisher","unstructured":"Rzymski, P., Poniedzia\u0142ek, B., Zar\u0119bska-Michaluk, D., Tomasiewicz, K., Flisiak, R. High seroprevalence and high risk: Why are older adults more prone to respiratory syncytial virus?. J Virol:e01432\u201325. https:\/\/doi.org\/10.1128\/jvi.01432-25","DOI":"10.1128\/jvi.01432-25"},{"key":"28414_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104988","volume":"144","author":"I Montesinos","year":"2021","unstructured":"Montesinos, I. et al. Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests. J. Clin. Virol. 144, 104988 (2021).","journal-title":"J. Clin. Virol."},{"key":"28414_CR51","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/jcm12051733","volume":"12","author":"L Brydak","year":"2023","unstructured":"Brydak, L. et al. Association between the seroprevalence of antibodies against seasonal alphacoronaviruses and SARS-CoV-2 humoral immune response, COVID-19 severity, and influenza vaccination. J. Clin. Med. 12, 1733 (2023).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28414-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28414-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28414-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:03:12Z","timestamp":1777388592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28414-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28414"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28414-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.J. reports lecture fees from Pfizer. P.R. reports grants, advisory, and lecture fees from Pfizer, Moderna, and Sanofi. The other authors declare no conflict of interest in relation to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the local Ethics Committee at the Centre of Postgraduate Medical Education in Warsaw (permission number 85\/2025) and conducted in accordance with the Helsinki Declaration with later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"44570"}}